SOD1 and amyotrophic lateral sclerosis: However, together with the molecules investigated in this study, additional soluble factors of a different nature, such as myokines or miRNAs, may represent new therapeutic molecules aimed at limiting muscle alterations in ALS patients; hence, future research needs to be focused on the characterization of the secreted proteome and released miRNA by hSOD1(WT) myocytes.